Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren Lasko, Kenneth D. Bromberg, Clarissa G. Jakob et al.|Nature|2017Cited by 853
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancerEmily J. Faivre, Yu Shen, Keith F. McDaniel et al.|Nature|2020Cited by 404
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory CancerChristopher D. Cox, George D. Hartman, Joseph P. Davide et al.|Journal of Medicinal Chemistry|2008Cited by 156
Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSPMark E. Fraley, George D. Hartman, R. M. Garbaccio et al.|Bioorganic & Medicinal Chemistry Letters|2006Cited by 64
Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSPKeith Rickert, Carolyn A. Buser, Michael D. Schaber et al.|Archives of Biochemistry and Biophysics|2007Cited by 50